Discussion
cataract, OAG, glaucoma
CATARACT, GLAUCOMA
A considerable shift from traditional glaucoma surgeries to MIGS procedures has occurred in recent years [The present report provides safety and effectiveness outcomes of phacoemulsification and ECP, either with or without iStent The combination of micro-bypass stent, cataract surgery, and ECP leverages different mechanisms of action in glaucoma management [These findings are consistent with the literature on ECP and trabecular micro-bypass. A retrospective consecutive case series by Ferguson et al. [Favorable trends also were observed in medication reduction in the current study, with the vast majority of eyes in both groups reducing their number of medications through Year 1. As with IOP, the medication reductions were significantly greater in the group undergoing iStent These medication reductions represent significant benefits at the level of each patient, given the well-known personal, physical, social, and financial consequences of chronic medication exposure. For example, the cost of chronic medication can be a financial burden for patients; not surprisingly, numerous studies have shown the cost effectiveness of the iStent device compared with the use of chronic topical medications [Both ECP and iStent These visual acuity findings are consistent with prior evaluations of phacoemulsification + ECP and/or iStent implantation [This study is limited by its modest sample size, 1 year follow-up duration, and inclusion of data from 2 surgeons at 2 sites. Patients with other forms of glaucoma than OAG were excluded, as well as those who had undergone previous glaucoma filtration surgery. The majority of patients in the study population were White, Hispanic, or Black, so results may not be directly applicable to other demographic groups (e.g., Asians). Not all data were available for all parameters at all time points. A future study could include a greater number of patients, longer duration of follow-up, data from more sites, or a broader range of glaucoma subtypes.